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INTRODUCTION
Depressive features are clearly recognized within
the context of schizophrenia (1, 2), and clarification
of the comorbidity has important clinical implications
particularly when choosing the best neuroleptics
for treatment. However, in some cases, it is difficult
to clearly distinguish between depressive symptoms,
negative symptoms and extrapyramidal side-effects
(3, 4), resulting in the poor correlation between
self-reports and observer reports on depression (5).
Therefore, self-rating scales may be more effective
than observer rating scales to assess depression in
schizophrenic patients.
The Zung Self-Rating Depression Scale (SDS) (6)
is a self-reporting scale composed of 20-item scales
that was developed to measure depressive symp-
toms using 4-point scales. The SDS was originally
designed to assess depression in patients with
depressive disorders. Psychometric research has
provided substantial evidence on the reliability and
validity of the SDS with normal subjects and patients
with depressive disorders (7). However, data on the
psychometric properties of the SDS with schizo-
phrenic subjects are in sufficient. This investigation
was designed to replicate and extend extant findings
regarding the psychometric properties of the SDS
among schizophrenics.
METHODS
The subjects were 110 medicated schizophrenic
inpatients (50 females and 60 males) that met the
DSM (Diagnostic and Statistical Manual of the
American Psychiatric Association)-IV (8) diagnostic
criteria for schizophrenia. Informed consent was
obtained from all subjects. The mean age of the sub-
jects was 49.6 years (SD=11.5, range 18-76) (Table1).
The mean duration of illness was 19.5 years (SD=
10.7, range 1-53). The presence or absence of de-
pression was determined using the DSM-IV criteria.
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At the time of assessment, 15 subjects showed de-
pressive signs and 95 subjects did not.
Test-retest reliability was assessed for 19 patients ;
retests were conducted within a mean period of
17.0 days (SD=5.6, range 8-25) after the first test.
Extrapyramidal symptoms (EPS) were assessed for
97 patients using the Drug Induced Extra-Pyramidal
Symptoms Scale (DIEPSS) (9, 10), which was re-
cently established in Japan. The DIEPSS is composed
of eight individual parameters and one global asses-
sment constructed to measure EPS, using 5-point
scales. The mean rating of overall severity was 1.1
(SD=0.9, range 0-3) (Table 1).
Statistical analyses were performed using non-
parametric tests (Mann Whitney’s U-test, Spearman
rank correlations).
Table 1. Demographic characteristics of subjects
N Age(yr)
Mean±SD
Duration of illness (yr)
Mean±SD
EPS (N=97)
Mean±SD
Total SDS scores
Mean±SD
Schizophrenics
Total
Depression (+)
Depression (-)
110
15
95
49.6±11.5
49.1±12.3
49.6±11.5
19.5±10.7
17.9±10.8
19.8±10.7
1.1± .9
1.1±1.0
1.1± .9
40.2±9.5
51.0±6.1***
38.5±8.8
SDS=the Zung Self-Rating Depression Scale ; EPS=extrapyramidal symptoms.
***p< .001 versus schizophrenics without depression by the Mann Whitney’s U-test.
Table 2. SDS scores and correlation coefficients
Schizophrenics Rs 1 Rs 2
Total
Mean±SD
Depressed
Mean±SD
Non-depressed
Mean±SD
Total
Item- 1 (Depressed affect)
Item- 2 (Diurnal variation)
Item- 3 (Crying spells)
Item- 4 (Sleep disturbance)
Item- 5 (Decreased appetite)
Item- 6 (Decreased libido)
Item- 7 (Weight loss)
Item- 8 (Constipation)
Item- 9 (Tachycardia)
Item-10 (Fatigue)
Item-11 (Confusion)
Item-12 (Psychomotor retardation)
Item-13 (Psychomotor agitation)
Item-14 (Hopelessness)
Item-15 (Irritability)
Item-16 (Indecisiveness)
Item-17 (Personal devaluation)
Item-18 (Emptiness)
Item-19 (Suicidal rumination)
Item-20 (Dissatisfaction)
40.2±9.5
1.7± .9
2.2±1.3
1.4± .7
1.7± .9
1.5± .9
3.2±1.0
1.8±1.0
1.7±1.1
1.4± .7
20.±1.0
2.2±1.2
2.1±1.2
1.7±1.0
3.0±3.9
1.5± .8
2.7±1.2
2.6±1.2
2.4±1.2
1.5±1.0
2.5±1.2
51.0±6.1***
2.2±1.0*
3.1±1.1**
1.8±1.1*
2.1±1.1
1.3± .8
3.1±1.1
1.9±1.1
2.3±1.3*
1.7± .7*
2.8± .9***
3.2± .9***
2.7±1.2*
2.4±1.2**
3.1±1.1
2.3± .9***
3.6± .6***
3.3±1.1*
3.3±1.0**
2.0±1.1**
3.1±1.2*
38.5±8.8
1.6± .9
2.1±1.2
1.3± .6
1.6± .9
1.5± .9
3.2±1.0
1.8±1.0
1.6±1.0
1.3± .7
1.9± .9
2.1±1.2
2.0±1.2
1.6±1.0
3.0±4.1
1.4± .7
2.5±1.1
2.5±1.2
2.2±1.2
1.5± .9
2.4±1.2
.87†††
.34
.72††
－.09
－.09
.84††
.50†
.50†
.64††
.92†††
.62†
.80††
.72††
.68††
.61†
－.09
.34
.66††
.86††
.62†
.85††
.06
－.01
－.07
.09
.13
.06
－.04
.12
.04
－.01
－.02
－.11
－.07
.17
.14
－.03
－.11
.05
.06
.06
－.02
Rs1=test-retest reliabililty coefficients by Spearman rank correlations ;
Rs2=coefficients of correlations between SDS scores and EPS by Spearman rank correlations.
*p<.05, ** p<.01 and ***p<.001 versus schizophrenics without depression by the U-test ;
†p<.05, ††p<.01 and†††p<.001 by Spearman rank correlations.
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RESULTS
Table 2 shows means and standard deviations of
the SDS for the whole sample, the subset of patients
without depression and the smaller subset of patients
with depression.
1. Internal Consistency
Cronbach’s alpha (11) was used to determine the
internal consistency of the SDS. Cronbach’s alpha
for the SDS was .81, and reached the acceptable
range for internal consistency.
2. Temporal Stability
Test-retest reliability was calculated for a subset
of 19 patients without depression. Spearman rank
correlations for the total SDS scores and each SDS
item score were, in ascending order, total=.87 (p<
.001), item-1=.34, item-2=.72 (p<.01), item-3=-.09,
item-4=-.09, item-5=.84 (p<.001), item-6=.50 (p<.05),
item-7=.50 (p<.05), item-8=.64 (p<.01), item-9=.92
(p<.001), item-10=.62 (p<.05), item-11=. 80 (p<.01),
item-12=.72 (p<.01), item-13=.68 (p<.01), item-14=
.61(p<.05), item-15=-.09, item-16=.34, item-17=.66
(p<.01), item-18=.86 (p<.001), item-19=.62 (p<.05)
and item-20=.85 (p<.001) (Table 2). The correlation
for the total SDS was clear, but the coefficients for
the SDS items revealed variability among items.
3. Validity
Using the Mann Whitney’s U-test, the mean total
SDS score for the 15 patients with depression was
significantly different from the group of patients
without depression, with p being <.001.
4. Relationships between SDS scores and EPS
Spearman rank correlations for the total SDS scores
and each SDS item score were, in ascending order,
total=.06, item-1=-.01, item-2=-.07, item-3=.09, item-4
=.13, item-5=.06, item-6=-.04, item-7=.12, item-8=.04,
item-9=-.01, item-10=-.02, item-11=-.11, item-12=-.07,
item-13=.17, item-14=.14, item-15=-.03, item-16=.11,
item-17=.05, item-18=.06, item-19=.06 and item-20=
-.02 (Table2). None of the 20 items or total SDS
was significantly correlated with EPS.
DISCUSSION
In an assessment of psychiatric symptoms,
self-reports and/or observer rating scales are fre-
quently used. In particular, observer rating scales
are useful, when the levels of psychiatric symptoms
are assessed. However, in a schizophrenic sample,
prior research has indicated inconsistent agreement
between self-reports and observer rating scales of
depression. Craig and van Natta (5) reported that
schizophrenics revealed no significant correlation
between four self-report scales and an observer
rating scale of depressed mood. In contrast, when
self-report scales are intercorrelated, patients showed
highly significant correlations. These results indi-
cated difficulty in assessing depressive symptoms
in schizophrenia by observer rating scales to assess
depression in schizophrenics. One of the main rea-
sons for the difficulty was the possible overlap with
negative symptoms and extrapyramidal side-effects.
Prosser et al . (3) reported that negative symptoms
were significantly correlated with some features of
depression in schizophrenics, and Van Putten and
May (4) reported that patients who developed akinesia
with antipsychotic drugs exhibited a significant
increase in depressive ratings. Therefore, consider-
ing these results and my findings in clinical practice,
self-rating scales may be more effective than observer
rating scales to assess depression in schizophrenic
patients. Thus, the psychometric potential of the
SDS, one of the commonly used self-rating scales,
was investigated.
In the present study, the internal consistency of
the SDS in schizophrenics was high. The test-retest
reliability coefficient for the total SDS in schizo-
phrenics was also as high as that in normal subjects
(r=.85, N=34) as shown by Fukuda and Kobayashi
(7). However, test-retest reliability coefficients for
the SDS items revealed variability among items.
These reliability coefficients suggest that scores on
some of the items changed substantially from test
to retest. This result may be explained by the pos-
sibility that the test-retest interval in some patients
was too long and the mental condition of the patients
changed slightly due to their psychotic symptoms.
In addition, none of the 20 items or total SDS was
significantly correlated with extrapyramidal symp-
toms.
Overall, the findings demonstrate the usefulness
of the psychometric properties of assessment instru-
ments when used with populations other than those
for which they were designed. However, due to
findings of mixed reliability, caution should be ex-
ercised when using the SDS with schizophrenics.
Although the SDS is a valuable tool for the as-
sessment of depression, the presence or absence of
depression must be carefully determined, not by a
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scale alone. Moreover, observer rating scales are
appropriate in patients who are unable to complete
self-rating scales.
CONCLUSION
The SDS is a useful tool to evaluate depression in
schizophrenics, although caution should be exercised
when it is employed.
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